Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02089425 · ClinicalTrials.gov registry record · Phase 3
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
A Phase 3 study, sponsored by Kowa Research Institute.
- Terminated
- Registry status
- Phase 3
- Development phase
- 384
- Enrollment target
NCT02089425 is a Phase 3 study that was terminated before completion, run by Kowa Research Institute. The registered enrollment target is 384 participants.
The verdict
NCT02089425, a Phase 3 study, was terminated before completion, sponsored by Kowa Research Institute.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 384 participants
- Enrollment target
Study Summary
This is a randomized, double blind, placebo controlled, parallel group study to assess the efficacy and safety of K-103-IP compared with placebo patch for treatment of mild to moderate acute pain associated with ankle strain or sprain.
Interventions
- DRUG Placebo
- DRUG K-103-IP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 384 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02089425
The ClinicalTrials.gov registry entry for NCT02089425 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 384 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02089425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02089425 about?
NCT02089425 is a clinical study titled "An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.". This is a randomized, double blind, placebo controlled, parallel group study to assess the efficacy and safety of K-103-IP compared with placebo patch for treatment of mild to moderate acute pain associated with ankle strain or sprain.
What is the current status of trial NCT02089425?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 384 participants. The study started on 2014-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02089425?
The interventions under investigation include: Placebo (DRUG), K-103-IP (DRUG).
Who is sponsoring clinical trial NCT02089425?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.